↓ Skip to main content

A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

Overview of attention for article published in Frontiers in endocrinology, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?
Published in
Frontiers in endocrinology, January 2012
DOI 10.3389/fendo.2012.00088
Pubmed ID
Authors

Imelda M. McGonnell, Agamemnon E. Grigoriadis, Eric W.-F. Lam, Joanna S. Price, Andrew Sunters

Abstract

The phosphoinositide 3-kinase and AKT (protein kinase B) signaling pathway (PI3K/AKT) plays a central role in the control of cell survival, growth, and proliferation throughout the body. With regard to bone, and particularly in osteoblasts, there is an increasing amount of evidence that the many signaling molecules exert some of their bone-specific effects in part via selectively activating some of the generic effects of the PI3K/AKT pathway in osteoblasts. There is further data demonstrating that PI3K/AKT has the capacity to specifically cross-talk with other signaling pathways and transcriptional networks controlling bone cells' development in order to fine-tune the osteoblast phenotype. There is also evidence that perturbations in the PI3K/AKT pathway may well be responsible for certain bone pathologies. In this review, we discuss some of these findings and suggest that the PI3K/AKT pathway is a central nexus in the extensive network of extracellular signaling pathways that control the osteoblast.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
France 1 1%
Unknown 71 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Ph. D. Student 13 18%
Student > Master 10 14%
Student > Bachelor 9 12%
Student > Doctoral Student 5 7%
Other 11 15%
Unknown 12 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 32%
Biochemistry, Genetics and Molecular Biology 19 26%
Medicine and Dentistry 10 14%
Engineering 2 3%
Immunology and Microbiology 1 1%
Other 3 4%
Unknown 15 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2012.
All research outputs
#22,756,649
of 25,371,288 outputs
Outputs from Frontiers in endocrinology
#8,329
of 13,004 outputs
Outputs of similar age
#228,471
of 250,083 outputs
Outputs of similar age from Frontiers in endocrinology
#89
of 138 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,004 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,083 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.